Ken Griffin's position in Dexcom is currently worth $133 Million. That's 0.13% of their equity portfolio (174th largest holding). The first Dexcom trade was made in Q2 2013. Since then Ken Griffin bought shares 57 more times and sold shares on 42 occasions. The stake costed the investor $80.3 Million, netting the investor a gain of 66% so far.